1 2349 135 USING THE MULTI-THEORY MODEL (MTM) OF HEALTH BEHAVIOR CHANGE TO EXPLAIN YOGA PRACTICE. BACKGROUND: DIVERSE GROUPS, INCLUDING COLLEGE STUDENTS, ARE BEING ENCOURAGED TO PRACTICE YOGA. RESEARCH SUGGESTS THAT COLLEGE STUDENTS FAIL TO ATTAIN THE MENTAL AND PHYSICAL BENEFITS OF YOGA PRACTICE. OBJETIVE: THE PURPOSE OF THIS STUDY WAS TO UTILIZE THE FOURTH-GENERATION, MULTI-THEORY MODEL (MTM) OF HEALTH BEHAVIOR CHANGE TO EXPLAIN CHANGE REGARDING YOGA PRACTICE OF ASANAS, SHAVA ASANA, PRANAYAMA, DHYANA, YAMA AND NIYAMA AMONG COLLEGE STUDENTS. METHOD: THIS CROSS-SECTIONAL STUDY RELIED ON A QUOTA SAMPLE OF STUDENTS 18 YEARS AND OLDER ATTENDING JACKSON STATE UNIVERSITY, A HISTORICALLY BLACK COLLEGE IN JACKSON, MISSISSIPPI, UNITED STATES. MEASURES: A 36-ITEM FACE AND CONTENT VALID INSTRUMENT WAS USED TO COLLECT DATA. STEPWISE MULTIPLE REGRESSION WAS USED TO ANALYZE THE SURVEY DATA FOR IDENTIFYING THE BEST POSSIBLE PREDICTORS OF YOGA PRACTICE. A STATISTICAL SIGNIFICANCE LEVEL OF 0.05 WAS SET A PRIORI. RESULTS: A TOTAL OF 70 PARTICIPANTS, MEAN AGE 28.62 YEARS (SD, 6.11), PREDOMINATELY FEMALE (84%) AND BLACK (87%) COMPLETED THE SURVEY. THE INITIATION MODEL CONSTRUCTS- CHANGES IN THE PHYSICAL ENVIRONMENT (BETA = 3.99, P = .002) AND BEHAVIORAL CONFIDENCE (BETA = 0.331, P = .008)-WERE SIGNIFICANT, EXPLAINING 40% OF THE VARIABILITY IN THE DEPENDENT VARIABLE. PRACTICE CHANGE WAS STATISTICALLY SIGNIFICANT (F1,65 =7.569; P = .0001; ADJUSTED R2 = 0.460) FOR THE MAINTENANCE MODEL, EXPLAINING 46% OF THE VARIABILITY. CONCLUSION: THE MTM MODEL OF HEALTH BEHAVIOR CHANGE IS EFFECTIVE FOR EXPLAINING THE INTENT TO INITIATE AND MAINTAIN YOGA BEHAVIOR AMONG COLLEGE STUDENTS. 2022 2 2241 17 THE INFLUENCE OF HATHA YOGA AS AN ADD-ON TREATMENT IN MAJOR DEPRESSION ON HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS ACTIVITY: A RANDOMIZED TRIAL. OBJECTIVES: THE IMPACT OF HATHA YOGA AS ADD-ON TREATMENT TO QUETIAPINE FUMARATE EXTENDED RELEASE (QXR) OR ESCITALOPRAM (ESC) IN DEPRESSED PATIENTS ON HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS ACTIVITY WAS ASSESSED. METHODS: 60 INPATIENTS SUFFERING FROM MAJOR DEPRESSIVE DISORDER (MDD) ACCORDING TO DSM-IV WERE RANDOMIZED FOR A 5 WEEK TREATMENT WITH YOGA OR NOT (CONTROL GROUP) AND WITH EITHER QXR (300 MG/DAY) OR ESC (10 MG/DAY). SERIAL DEXAMETHASONE/CORTICOTROPIN RELEASING HORMONE (DEX/CRH) TESTS WERE PERFORMED TO ASSESS HPA AXIS FUNCTION. THE HAMILTON DEPRESSION RATING SCALE (21-HAMD) WAS USED WEEKLY. RESULTS: A MORE PRONOUNCED DOWN REGULATION OF THE HPA AXIS ACTIVITY DUE TO YOGA COULD NOT BE DETECTED. THE STEPWISE LONG TERM CORTISOL REDUCTION WAS SEEN IN BOTH MEDICATION GROUPS, IRRESPECTIVELY OF YOGA ADD-ON TREATMENT. IN ADDITION, CORTISOL IMPROVERS IN WEEK 1 OF THERAPY (REDUCTION IN CORTISOL PEAK VALUE WITHIN THE DEX/CRH TEST) REACHED SIGNIFICANT GREATER AMELIORATION OF DEPRESSIVE SYMPTOMS AFTER 5 WEEKS. CONCLUSIONS: OUR RESULTS SUGGEST THAT ANTIDEPRESSANT AGENTS DOWN REGULATE HPA AXIS FUNCTION TO A GREATER EXTENT THAN ADDITIONAL HATHA YOGA TREATMENT. MOREOVER, AN EARLY REDUCTION OF HPA SYSTEM HYPERACTIVITY AFTER ONE WEEK OF PHARMACOLOGICAL TREATMENT SEEMS TO RAISE THE POSSIBILITY OF A FAVORABLE TREATMENT RESPONSE. 2014 3 2063 30 THE BENEFITS OF YOGA PRACTICE COMPARED TO PHYSICAL EXERCISE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS. YOGA IS INCREASINGLY USED AS AN ADJUNCTIVE THERAPY IN THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS (T2DM). THE PRESENT STUDY AIMS TO SYSTEMATICALLY EVALUATE THE LITERATURE AND PERFORM A META-ANALYSIS ON THE EFFECTS OF YOGA PRACTICE COMPARED TO PHYSICAL EXERCISE IN THE MANAGEMENT OF T2DM. DATA WERE OBTAINED USING A STEPWISE SEARCH PROCESS USING KEYWORDS IN THE FOLLOWING ONLINE MEDICAL DATABASES; PUBMED, WEB OF SCIENCE AND SCOPUS. ALL CONTROLLED CLINICAL TRIALS INVOLVING PATIENTS WITH T2DM, COMPARING YOGA AS AN INTERVENTION WITH PHYSICAL EXERCISE AND EVALUATING GLYCAEMIC CONTROL AND OTHER OUTCOMES BETWEEN THE INTERVENTION AND CONTROL GROUPS WERE INCLUDED IN THE ANALYSIS. EIGHT STUDIES WERE ELIGIBLE TO BE INCLUDED IN THE SYSTEMATIC REVIEW. IN TOTAL, 842 PARTICIPANTS WERE ASSIGNED TO A YOGA INTERVENTION OR A CONTROL GROUP WITH AN EXERCISE INTERVENTION AND THE AGE RANGE OF PARTICIPANTS WAS 30-78 YEARS. A SIGNIFICANT REDUCTION IN FBG (15.16MG/DL), PPBG (28.66MG/DL), HBA1C (0.39%) AND BMI (0.71KG/M2) WAS NOTED IN THE INTERVENTION GROUP ('YOGA') COMPARED TO THE CONTROL GROUP ('PHYSICAL EXERCISE') IN THE POOLED ANALYSIS. WE DID NOT OBSERVE ANY SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS FOR LIPID PARAMETERS, OTHER BODY COMPOSITION MEASURES (WC AND WHR) AND BLOOD PRESSURE. IN CONCLUSION, OUR RESULTS SHOW THAT YOGA HAS BENEFICIAL EFFECTS ON GLYCAEMIC CONTROL IN COMPARISON TO PHYSICAL EXERCISE IN T2DM HOWEVER, INDIVIDUAL STUDIES SHOWED CONSIDERABLE HETEROGENEITY. HENCE, FURTHER WELL-CONTROLLED RANDOMIZED TRIALS ARE REQUIRED PRIOR TO DRAWING CONCLUSIONS ABOUT THE BENEFITS OF YOGA IN COMPARISON TO PHYSICAL EXERCISE. 2018 4 1782 21 PREDICTORS OF FUNCTIONAL IMPROVEMENTS AFTER THERAPEUTIC YOGA INTERVENTION FOR PEOPLE WITH PARKINSON'S DISEASE. PARKINSON'S DISEASE (PD) AFFECTS NEARLY 10 MILLION PEOPLE WORLDWIDE, LEADING TO DECREASED MOBILITY AND BALANCE AND POTENTIAL LOSS OF INDEPENDENCE. YOGA HAS BEEN ASSOCIATED WITH IMPROVED FUNCTION FOR PEOPLE WITH PD, BUT THE PREDICTIVE FACTORS FOR IMPROVED FUNCTIONAL OUTCOMES AS A RESULT OF YOGA PARTICIPATION REMAIN UNEXAMINED. THE OBJECTIVE OF THIS SECONDARY DATA ANALYSIS WAS TO IDENTIFY PREDICTIVE FACTORS OF FUNCTIONAL IMPROVEMENT FOR PEOPLE WITH PD AFTER AN 8-WEEK YOGA INTERVENTION. STEPWISE MULTIPLE LINEAR REGRESSION WAS USED TO IDENTIFY SIGNIFICANT PREDICTORS OF IMPROVEMENT IN BALANCE, FALL CONTROL, PD SYMPTOMS, AND ACTIVITY CONSTRAINTS. LOWER COGNITIVE FUNCTIONING WAS PREDICTIVE OF IMPROVEMENT IN PERCEIVED CONTROL OVER FALLS, BODY RESPONSIVENESS WAS PREDICTIVE OF IMPROVEMENT IN PD-SPECIFIC SYMPTOMS, AND GAIT VELOCITY WAS PREDICTIVE OF IMPROVEMENT IN BALANCE AND ACTIVITY CONSTRAINTS. FUTURE RESEARCH IS WARRANTED TO EVALUATE THE USE OF SCREENERS TO PREDICT WHO IS THE BEST FIT FOR YOGA THERAPY. ADDITIONAL RESEARCH IS NEEDED TO EVALUATE THE NEED TO INCLUDE COGNITIVE SELF-MANAGEMENT TRAINING CONCURRENT WITH YOGA THERAPY. 2020 5 2608 11 YOGA FOR PSYCHIATRIC DISORDERS: FROM FAD TO EVIDENCE-BASED INTERVENTION? THERE IS GROWING EVIDENCE FOR YOGA'S NEUROBIOLOGICAL EFFECTS IN PEOPLE WITH PSYCHIATRIC DISORDERS. POSTULATED MECHANISMS OF ACTION INCLUDE: (A) MODULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS; (B) ENHANCEMENT OF GABAERGIC NEUROTRANSMISSION; (C) AUTONOMIC MODULATION; AND (D) NEUROENDOCRINOLOGICAL EFFECTS. YOGA AS A THERAPEUTIC INTERVENTION IN PSYCHIATRIC DISORDERS APPEARS PROMISING AND MERITS FURTHER ATTENTION IN CLINICAL PRACTICE AND RESEARCH. 2020 6 1581 18 MECHANISM OF ACTION OF YOGA ON PREVENTION AND MANAGEMENT OF TYPE 2 DIABETES MELLITUS: NARRATIVE REVIEW. BACKGROUND: RESEARCH IN INDIA HAS RECOGNIZED TYPE 2 DIABETES MELLITUS (T2DM) AND PREDIABETES (PDM) AS PSYCHOSOMATIC METABOLIC ENDOCRINE DISORDERS CHARACTERIZED BY GLYCEMIC DISHARMONY. THIS REVIEW AIMED AT COLLATING INFORMATION FROM PUBLISHED E-PAPERS ON MECHANISM OF ACTION (MOA) OF YOGA THERAPY(YT) AND INTEGRATED APPROACH OF YOGA THERAPY (IAYT) ON PDM AND T2DM. METHOD: CONTENT ON YT AND THE MOA ON PREVENTION AND MANAGEMENT OF T2DM WERE EXTRACTED FROM ONLINE SOURCES SUCH AS PUBMED, GOOGLE SCHOLAR, COCHRANE LIBRARY AND LIBRARY GENESIS. THIS REVIEW INCLUDED 58 ARTICLES RELATED TO PREDIABETES, T2DM, PRE-DIABETES TO T2DM CONVERSION, MECHANISM OF ACTION OF YOGA, YOGA AND T2DM, PREDIABETES AND YOGA. ARTICLES RELATED TO TYPE 1 DIABETES, DIABETES INSIPIDUS AND GESTATIONAL DIABETES WERE EXCLUDED. RESULT: CURRENT SCIENTIFIC REVIEW RESULTED IN UNDERSTANDING THE DIFFERENT MECHANISMS INVOLVED IN REJUVENATING EFFECT OF YOGA AS YT AND IAYT IN PREDIABETES AND T2DM. HOWEVER, THE VARIOUS MECHANISMS BY WHICH THE INTERVENTIONS WORK ARE UNDERSTOOD EITHER THROUGH A SINGLE OR COMBINED IMPACT ON REGAINING AUTONOMIC BALANCE, VAGAL MODULATION, REGULATION OF HORMONES AND THEREBY ATTAINING GLYCEMIC CONTROL. MOREOVER, THESE MECHANISMS ARE THE FORTHCOMINGS OF THE CROSS TALK BETWEEN BRAIN, MIND AND BODY SYSTEMS UNDER BRANCHES OF NEUROPHYSIOLOGY, NEUROENDOCRINOLOGY, PSYCHOPHYSIOLOGY, PSYCHO NEUROENDOCRINOLOGY AND/OR NEUROPSYCHOLOGY. CONCLUSION: EVIDENCE SOUGHT FROM PUBLISHED RESEARCH WORKS PROCLAIM YT BASED LIFE STYLE MODIFICATION FOR PREVENTION AND MANAGEMENT OF T2DM. SUMMING UP, THE EFFECT IS STIPULATED BASED ON THE APPROACH, METHOD OF PRACTICE, TIME OF THE DAY, BELIEF AND DEDICATION OF THE PRACTITIONERS. 2022 7 103 31 A PILOT CROSS-SECTIONAL SURVEY ON AWARENESS AND PRACTICE REGARDING TYPE 2 DIABETES MELLITUS AND ITS MANAGEMENT WITH YOGA. DIABETES MELLITUS IS A METABOLIC DISORDER OF MULTIPLE ETIOLOGY, CHARACTERIZED BY CHRONIC HYPERGLYCAEMIA WITH DISTURBANCE OF CARBOHYDRATE, FAT, AND PROTEIN METABOLISM RESULTING FROM DEFECT IN INSULIN SECRETION, INSULIN ACTION OR BOTH. IMPROPER LIFESTYLE CONTRIBUTES TO THE INCREASING NUMBER OF PEOPLE AFFECTED WITH TYPE 2 DIABETES MELLITUS (T2DM). SYSTEMATIC REVIEWS ON THE MANAGEMENT OF T2DM IN ADULTS THROUGH YOGA REPORTED SIGNIFICANT IMPROVEMENTS IN MULTIPLE MODIFIABLE INDICES OF DIABETES MELLITUS MANAGEMENT INCLUDING GLYCEMIC CONTROL, LIPID LEVELS, AND BODY COMPOSITION. AWARENESS LEVELS OF A CONDITION AMONG THE POPULATION PLAY A CRITICAL ROLE IN BEHAVIOUR CHANGE. HOWEVER, STUDIES RELATED TO ASSESSING THE AWARENESS AND PRACTICE OF YOGA FOR MANAGING DISEASES ARE LIMITED. HENCE, THIS STUDY WAS FORMULATED WITH THE OBJECTIVE OF ASSESSING THE AWARENESS LEVEL AND EXTENT OF KNOWLEDGE ABOUT DIABETES MELLITUS AND ITS MANAGEMENT THROUGH YOGA. A CROSS-SECTIONAL SURVEY WITH A SAMPLE SIZE OF 317 WAS CONDUCTED USING A STRUCTURED QUESTIONNAIRE AT 5 DISTRICTS IN TAMIL NADU AND KERALA. 95% OF THE STUDY POPULATION WERE AWARE OF DIABETES MELLITUS WHILE 61.2% RESPONDED THAT DIABETES CAN BE PREVENTED BY REGULAR EXERCISE AND HEALTHY DIET. 62.4% PEOPLE PERCEIVED THAT YOGA PRACTICES CAN PREVENT DIABETES MELLITUS AND 59% MENTIONED THAT REGULAR YOGA PRACTICE CAN HELP IN CONTROLLING DIABETES AND PREVENT FURTHER COMPLICATIONS. ONLY 13% REPORTED TO PRACTICE YOGA REGULARLY AT LEAST THREE DAYS A WEEK. IDENTIFYING A QUALIFIED YOGA TRAINER WAS REPORTED TO BE A LIMITING FACTOR FOR REGULAR YOGA PRACTICE. THE STUDY SUGGESTED THAT THERE IS A NEED TO INCREASE THE ACCESS TO QUALIFIED YOGA PROFESSIONALS AT COMMUNITY LEVEL. FURTHER LARGE SCALE STUDIES WITH RANDOM SAMPLING METHOD TO ASSESS THE AWARENESS LEVEL AND PRACTICE OF YOGA IN DIFFERENT SETTINGS IS INDICATED. 2020 8 2298 15 THERAPEUTIC ROLE OF YOGA IN TYPE 2 DIABETES. YOGA ORIGINATED IN INDIA MORE THAN 5,000 YEARS AGO AND IS A MEANS OF BALANCING AND HARMONIZING THE BODY, MIND, AND EMOTIONS. YOGA PRACTICE IS USEFUL IN THE MANAGEMENT OF VARIOUS LIFESTYLE DISEASES, INCLUDING TYPE 2 DIABETES. PSYCHO-NEURO-ENDOCRINE AND IMMUNE MECHANISMS ARE INVOLVED IN THE BENEFICIAL EFFECTS OF YOGA ON DIABETES. INCORPORATION OF YOGA PRACTICE IN DAILY LIFE HELPS TO ATTAIN GLYCAEMIC CONTROL AND REDUCES THE RISK OF COMPLICATIONS IN PEOPLE WITH DIABETES. IN THIS REVIEW, WE BRIEFLY DESCRIBE THE ROLE OF VARIOUS YOGA PRACTICES IN THE MANAGEMENT OF DIABETES BASED ON EVIDENCE FROM VARIOUS CLINICAL STUDIES. 2018 9 2057 22 THE BENEFITS OF YOGA FOR ADULTS WITH TYPE 2 DIABETES: A REVIEW OF THE EVIDENCE AND CALL FOR A COLLABORATIVE, INTEGRATED RESEARCH INITIATIVE. TYPE 2 DIABETES (T2DM) IS A GLOBAL PUBLIC HEALTH CRISIS. RESEARCH SUGGESTS THAT YOGA HOLDS PROMISE FOR T2DM MANAGEMENT. THIS ARTICLE SUMMARIZES EVIDENCE REGARDING THE EFFICACY OF YOGA FOR T2DM MANAGEMENT AND ENCOURAGES THE DEVELOPMENT OF AN INTEGRATED RESEARCH AGENDA AND A COLLABORATIVE WORK GROUP TO TEST IT. WE PRESENT A BRIEF OVERVIEW OF THE GLOBAL RISE IN T2DM AND ITS CONSEQUENCES AND COSTS, REVIEW THE EVIDENCE REGARDING THE POTENTIAL BENEFITS OF YOGA FOR T2DM MANAGEMENT, OUTLINE LIMITATIONS IN THE LITERATURE, DISCUSS POSSIBLE MECHANISMS UNDERLYING THE EFFECTS OF YOGA ON T2DM, AND SUGGEST HOW A COLLABORATIVE, MULTINATIONAL EFFORT BY YOGA THERAPIST AND RESEARCH COMMUNITIES MIGHT CONTRIBUTE TO RESEARCH AND INFORM CLINICAL PRACTICE. YOGA PROTOCOLS THAT SERVE T2DM PATIENTS AND A RESEARCH FRAMEWORK FOR CREATING AN EVIDENCE BASE TO SUPPORT THE USE OF YOGA FOR T2DM MANAGEMENT ARE CLEARLY NEEDED. 2013 10 1924 19 ROLE OF YOGA FOR PATIENTS WITH TYPE II DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS. TO UNDERSTAND THE ROLE AND EFFICACY OF YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS, THIS META-ANALYSIS WAS CONDUCTED. ELECTRONIC DATA BASES SEARCHED WERE PUBMED/MEDLINE, PROQUEST, PSYCINFO, INDMED, CENTRAL, COCHRANE LIBRARY, CAMQUEST AND CAMBASE TILL DECEMBER 17, 2014. ELIGIBLE OUTCOMES WERE FASTING BLOOD SUGAR (FBS), POST PRANDIAL BLOOD SUGAR (PPBS) AND GLYCOSYLATED HAEMOGLOBIN (HBA1C). RANDOMIZED CONTROLLED TRIALS AND CONTROLLED TRIALS WERE ELIGIBLE. STUDIES FOCUSSING ONLY ON RELAXATION OR MEDITATION OR MULTIMODAL INTERVENTION WERE NOT INCLUDED. A TOTAL OF 17 RCTS WERE INCLUDED FOR REVIEW. DATA FROM RESEARCH ARTICLES ON PATIENTS, METHODS, INTERVENTIONS- CONTROL AND RESULTS WERE EXTRACTED. MEAN AND STANDARD DEVIATIONS WERE UTILIZED FOR CALCULATING STANDARDIZED MEAN DIFFERENCE WITH 95% CONFIDENCE INTERVAL. HETEROGENEITY WAS ASSESSED WITH THE HELP OF I(2) STATISTICS. CHI(2) WAS USED TO RULE OUT THE EFFECTS OF HETEROGENEITY DUE TO CHANCE ALONE. BENEFICIAL EFFECTS OF YOGA AS AN ADD-ON INTERVENTION TO STANDARD TREATMENT IN COMPARISON TO STANDARD TREATMENT WERE OBSERVED FOR FBS [STANDARDIZED MEAN DIFFERENCE (SMD) -1.40, 95%CI -1.90 TO -0.90, P<0.00001]; PPBS [SMD -0.91, 95%CI -1.34 TO -0.48, P<0.0001] AS WELL AS HBA1C [SMD -0.64, 95%CI -0.97 TO -0.30, P<0.0002]. BUT RISK OF BIAS WAS OVERALL HIGH FOR INCLUDED STUDIES. WITH THIS AVAILABLE EVIDENCE, YOGA CAN BE CONSIDERED AS ADD-ON INTERVENTION FOR MANAGEMENT OF DIABETES. 2016 11 1805 29 PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS: A PILOT CROSS-SECTIONAL STUDY IN TWO DISTRICTS IN INDIA. INTRODUCTION: DIABETES IS ONE OF THE MAJOR HEALTH DISEASES IN THE WORLD TODAY. THE EFFICACY OF YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES IS WELL-ESTABLISHED. THE AIM OF THIS STUDY WAS TO ASSESS THE PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS IN TWO DISTRICTS OF INDIA (ONE EACH IN WEST AND SOUTH OF INDIA). METHODOLOGY: IN THIS CROSS-SECTIONAL FIELD STUDY, 155 YOGA PRACTITIONERS FROM PUNE AND 192 FROM ERNAKULAM DISTRICTS WERE ASSESSED USING THE DIABETES RISK TEST AND FASTING BLOOD SUGAR. THE DATA COLLECTED WERE ENTERED IN A STATISTICS SOFTWARE PACKAGE AND ANALYZED USING THE PEARSON'S CORRELATION ANALYSIS, T-TEST, UNIVARIATE ANOVA, AND LINEAR REGRESSION TO UNDERSTAND THE PREDICTORS OF RISK FOR DIABETES. RESULTS: THE OVERALL PREVALENCE OF DIABETES AMONG YOGA PRACTITIONERS IN CENTRAL PUNE WAS 3.6% (95% CONFIDENCE INTERVAL [CI]: [0.01-0.04]). 18.9% OF PARTICIPANTS (95% CI: [0.16-0.19]) WERE DIAGNOSED TO BE "AT RISK" FOR DIABETES. IN ERNAKULAM, THE OVERALL PREVALENCE OF DIABETES AMONG PRACTITIONERS WAS 26% (95% CI: [0.05-0.06]) WITH 12% OF PRACTITIONERS (95% CI: [0.05-0.06]) DIAGNOSED TO BE "AT RISK" FOR DIABETES (PREDIABETIC). HIGHER AGE AND LESSER DURATION OF YOGA PRACTICE WERE SIGNIFICANT PREDICTORS OF DIABETES. CONCLUSION: IT IS ESSENTIAL FOR EVERY PERSON ABOVE THE AGE OF 40 TO UNDERGO REGULAR HEALTH CHECK-UPS AND SCREENING FOR DIABETES AND INVOLVE ONESELF IN LIFESTYLE MODIFICATION PROGRAMS SUCH AS YOGA FOR SIGNIFICANTLY LONG DURATION OF TIME ON A DAILY BASIS, TO BETTER MANAGE DIABETES. 2015 12 2069 9 THE DIFFERENCES BETWEEN YOGA TEACHER TRAINING AND YOGA THERAPIST TRAINING AND THE DISTINCTION BETWEEN YOGA TEACHING AND YOGA THERAPY. THIS IS A SET OF INVITED PERSPECTIVES ON TWO KEY POLICY ISSUES: THE DIFFERENCES BETWEEN YOGA TEACHER TRAINING AND YOGA THERAPIST TRAINING AND THE DISTINCTION BETWEEN YOGA TEACHING AND YOGA THERAPY. 2014 13 2907 15 [ON THE METHODOLOGICAL APPROACH TO THE ELUCIDATION OF MECHANISMS UNDERLYING THERAPEUTIC EFFECTIVENESS OF CIGUN, INDIAN AND TIBETAN YOGA THERAPY]. THE METHODOLOGICAL APPROACH IS PROPOSED ALLOWING TO OBJECTIVELY CHARACTERIZE NEUROPHYSIOLOGICAL MECHANISMS UNDERLYING THERAPEUTIC EFFECTIVENESS OF CIGUN, INDIAN AND TIBETAN YOGA THERAPY. EXECUTION OF EXERCISES STIPULATED IN THESE PROGRAMS IS INTERPRETED AS A CONSCIOUSNESS-INSPIRED SPECIFIC FORM OF HUMAN BEHAVIOUR (ACTIVITY). STEP-BY-STEP ANALYSIS OF MENTALLY-ORGANIZED BODY'S FUNCTIONAL SYSTEMS AS A NEUROPHYSIOLOGICAL BASIS OF REALIZABLE BEHAVIOUR IS PRESENTED. OPERATIONAL INTERPRETATION OF INTERNAL MECHANISMS UNDERLYING THE SYSTEM'S FUNCTIONING PERMITS TO EVALUATE THE STEREOTYPE BRAIN CONDITION ACTUALIZED BY SPECIFIC REQUIREMENTS AND MOTIVATIONS THAT INITIATES SENSORY DEPRIVATION TO ENSURE PRIORITY REALIZATION OF INTERNAL GENETICALLY DETERMINED ACTIVITY OF THE HUMAN BODY. MOBILIZATION OF THIS INTERNAL ACTIVITY IS DESCRIBED AS A PROCESS OF SELECTIVE FORMATION OF MANY COMPLICATED INTERACTIONS BETWEEN VARIOUS STRUCTURES OF THE RETICULAR FORMATION, LIMBIC SYSTEM, SUBCORTICAL CENTRES, AND NEOCORTEX MAINTAINING PRIORITY FUNCTIONING OF HOMEOSTATIC MECHANISMS OF SELF-REGULATION AND INBORN HUMAN BEHAVIOUR. THESE MECHANISMS ARE BELIEVED TO UNDERLIE THE AUTORECONSTRUCTIVE POTENTIAL OF HUMAN ORGANISM BY ENSURING SYSTEMIC CORRECTION AND RESTORATION OF ITS FUNCTIONAL RESOURCES. 2010 14 2889 36 YOGA: MANAGING OVERWEIGHT IN MID-LIFE T2DM. BACKGROUND: THE DRAMATIC RISE IN THE PREVALENCE OF OBESITY AND TYPE 2 DIABETES MELLITUS (T2DM) IS ASSOCIATED WITH INCREASED MORTALITY, MORBIDITY AS WELL AS PUBLIC HEALTH CARE EXPENSES WORLDWIDE. PREVIOUS RESEARCH SUGGESTS THAT YOGA HOLDS PROMISE FOR OBESITY AND T2DM MANAGEMENT. OBJECTIVE: THE OBJECTIVE OF THE PRESENT STUDY WAS TO ASSESS THE EFFECT OF INTENSIVE INTEGRATED APPROACH OF YOGA THERAPY (IAYT) ON BODY FAT AND BODY MASS INDEX (BMI) AND RESTING METABOLISM IN MID-LIFE OVERWEIGHT PATIENTS WITH T2DM (BMI, MEAN +/- SD, 27.05 +/- 4.51). MATERIALS AND METHODS: TWENTY-FOUR MID-LIFE PATIENTS (6 FEMALES) WITH T2DM (AGE, MEAN +/- SD, 55.38 +/- 7.96 YEARS) PARTICIPATED IN THE STUDY AND PRACTICED IAYT FOR 7 DAYS. THE IAYT WORKS AT FIVE LAYERS OF HUMAN EXISTENCE (PHYSICAL, VITAL, MENTAL, INTELLECTUAL AND BLISS) TO BRING POSITIVE HEALTH. THE BODY FAT AND BMI AND RESTING METABOLISM WERE RECORDED BEFORE AND AFTER IAYT USING KARADA SCAN BODY COMPOSITION MONITOR HBF-375 FROM OMRON HEALTHCARE SINGAPORE PTE LTD. STATISTICAL ANALYSIS: SPSS-16 WAS USED TO ANALYZE THE DATA. SHAPIRO-WILK TEST SHOWED THAT THE DATA WAS NOT NORMALLY DISTRIBUTED. FURTHER, THE WILCOXON SIGNED-RANKS TEST WAS USED TO ANALYZE THE CHANGE IN MEANS OF PRE- AND POST-MEASUREMENTS. RESULTS: DATA ANALYSIS SHOWED THAT THERE WAS A SIGNIFICANT DECREASE IN BODY FAT AND BMI AND RESTING METABOLISM (IN ALL ASSESSMENTS, P < 0.001). CONCLUSION: THE PRESENT STUDY SUGGESTS THAT 7 DAYS PRACTICE OF IAYT HAS A GREAT PROMISE FOR THE MANAGEMENT OF OVERWEIGHT IN MID-LIFE PATIENTS WITH T2DM. ADDITIONAL WELL-DESIGNED STUDIES ARE NEEDED BEFORE A STRONG RECOMMENDATION CAN BE MADE. 2015 15 922 18 EFFECTIVENESS OF YOGA FOR HYPERTENSION: SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES. TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR REDUCING BLOOD PRESSURE IN ADULTS WITH HYPERTENSION AND TO ASSESS THE MODIFYING INFLUENCES OF TYPE AND LENGTH OF YOGA INTERVENTION AND TYPE OF COMPARISON GROUP. METHODS. ACADEMIC SEARCH PREMIER, ALTHEALTHWATCH, BIOSIS/BIOLOGICAL ABSTRACTS, CINAHL, COCHRANE LIBRARY, EMBASE, MEDLINE, PSYCINFO, PSYCARTICLES, NATURAL STANDARD, AND WEB OF SCIENCE DATABASES WERE SCREENED FOR CONTROLLED STUDIES FROM 1966 TO MARCH 2013. TWO AUTHORS INDEPENDENTLY ASSESSED RISK OF BIAS USING THE COCHRANE RISK OF BIAS TOOL. RESULTS. ALL 17 STUDIES INCLUDED IN THE REVIEW HAD UNCLEAR OR HIGH RISK OF BIAS. YOGA HAD A MODEST BUT SIGNIFICANT EFFECT ON SYSTOLIC BLOOD PRESSURE (SBP) (-4.17 [-6.35, -1.99], P = 0.0002) AND DIASTOLIC BLOOD PRESSURE (DBP) (-3.62 [-4.92, -1.60], P = 0.0001). SUBGROUP ANALYSES DEMONSTRATED SIGNIFICANT REDUCTIONS IN BLOOD PRESSURE FOR (1) INTERVENTIONS INCORPORATING 3 BASIC ELEMENTS OF YOGA PRACTICE (POSTURES, MEDITATION, AND BREATHING) (SBP: -8.17 MMHG [-12.45, -3.89]; DBP: -6.14 MMHG [-9.39, -2.89]) BUT NOT FOR MORE LIMITED YOGA INTERVENTIONS; (2) YOGA COMPARED TO NO TREATMENT (SBP: -7.96 MMHG [-10.65, -5.27]) BUT NOT FOR EXERCISE. CONCLUSION. YOGA CAN BE PRELIMINARILY RECOMMENDED AS AN EFFECTIVE INTERVENTION FOR REDUCING BLOOD PRESSURE. ADDITIONAL RIGOROUS CONTROLLED TRIALS ARE WARRANTED TO FURTHER INVESTIGATE THE POTENTIAL BENEFITS OF YOGA. 2013 16 2161 20 THE EFFECTS OF YOGA AMONG ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS. THE PURPOSE OF THIS META-ANALYSIS WAS TO EXAMINE THE EFFECTS OF YOGA FOR GLYCEMIC CONTROL AMONG ADULTS WITH TYPE 2 DIABETES (T2DM). COMPREHENSIVE ELECTRONIC DATABASES SEARCHES LOCATED 2559 UNIQUE STUDIES WITH RELEVANT KEY TERMS. STUDIES WERE INCLUDED IF THEY (1) EVALUATED A YOGA INTERVENTION TO PROMOTE T2DM MANAGEMENT, (2) USED A COMPARISON GROUP, (3) REPORTED AN OBJECTIVE MEASURE OF GLYCEMIC CONTROL AT POST-INTERVENTION, AND (4) HAD FOLLOW-UP LENGTH OR POST-TEST OF AT LEAST 8WEEKS FROM BASELINE. INDEPENDENT RATERS CODED PARTICIPANT, DESIGN AND METHODOLOGICAL CHARACTERISTICS AND INTERVENTION CONTENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. TWENTY-THREE STUDIES WITH 2473 PARTICIPANTS (MEAN AGE=53YEARS; 43% WOMEN) MET ELIGIBILITY CRITERIA. COMPARED WITH CONTROLS, YOGA PARTICIPANTS WERE SUCCESSFUL IN IMPROVING THEIR HBA1C (D+=0.36, 95% CI=0.16, 0.56; K=16), FBG (D+=0.58, 95% CI=0.40, 0.76; K=20), AND PPBG (D+=0.40, 95% CI=0.23, 0.56; K=14). YOGA WAS ALSO ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN LIPID PROFILE, BLOOD PRESSURE, BODY MASS INDEX, WAIST/HIP RATIO AND CORTISOL LEVELS. OVERALL, STUDIES SATISFIED AN AVERAGE OF 41% OF THE METHODOLOGICAL QUALITY (MQ) CRITERIA; MQ SCORE WAS NOT ASSOCIATED WITH ANY OUTCOME (PS >0.05). YOGA IMPROVED GLYCEMIC OUTCOMES AND OTHER RISK FACTORS FOR COMPLICATIONS IN ADULTS WITH T2DM RELATIVE TO A CONTROL CONDITION. ADDITIONAL STUDIES WITH LONGER FOLLOW-UPS ARE NEEDED TO DETERMINE THE LONG-TERM EFFICACY OF YOGA FOR ADULTS WITH T2DM. 2017 17 988 25 EFFECTS OF HATHA YOGA ON BLOOD PRESSURE, SALIVARY ALPHA-AMYLASE, AND CORTISOL FUNCTION AMONG NORMOTENSIVE AND PREHYPERTENSIVE YOUTH. OBJECTIVE: EVIDENCE IS ACCUMULATING, PREDOMINANTLY AMONG CLINICAL TRIALS IN ADULTS, THAT YOGA IMPROVES BLOOD PRESSURE (BP) CONTROL, WITH DOWNREGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS AND THE SYMPATHETIC NERVOUS SYSTEM (SNS) PROJECTED AS UNDERLYING MECHANISMS. THIS PILOT STUDY ASSESSED WHETHER HATHA YOGA HAS THE POTENTIAL TO REDUCE BP AMONG YOUTH AND WHETHER DAMPENING OF THE SNS AND/OR HPA ACTIVITY IS A LIKELY PATHWAY OF CHANGE. DESIGN: THIRTY-ONE SEVENTH GRADERS WERE RANDOMLY ASSIGNED TO A HATHA YOGA PROGRAM (HYP) OR ATTENTION CONTROL (AC) MUSIC OR ART CLASS. BASELINE AND 3-MONTH EVALUATIONS INCLUDED RESTING BP; OVERNIGHT URINE SAMPLES; AND SALIVA COLLECTED AT BEDTIME, UPON AWAKENING, AND AT 30 AND 60 MINUTES AFTER AWAKENING FOR ALPHA-AMYLASE AND CORTISOL ASSAYS. RESULTS: TWENTY-EIGHT (14 IN THE HYP GROUP AND 14 IN THE AC GROUP) STUDENTS WERE ASSESSED BOTH BEFORE AND AFTER THE INTERVENTION. BP CHANGES FROM PRE- TO POST-INTERVENTION WERE -3.0/-2.0 MMHG FOR THE HYP GROUP AND -0.07/-0.79 MMHG FOR THE AC GROUP (P=0.30 AND 0.57, RESPECTIVELY). CHANGES IN SYSTOLIC BP (SBP)/DIASTOLIC BP (DBP) FOR THE PREHYPERTENSIVE (75TH-94TH PERCENTILES FOR SBP) SUBGROUP ANALYSES WERE -10.75/-8.25 MMHG FOR THE HYP GROUP (N=4) VERSUS 1.8/1.0 MMHG FOR THE AC GROUP (N=5) (P FOR SBP=0.02; P FOR DBP=0.09). ALTHOUGH NO STATISTICALLY SIGNIFICANT GROUP DIFFERENCES WERE OBSERVED WITH CHANGES IN SNS OR HPA AWAKENING CURVES (AREA UNDER CURVE FOR ALPHA-AMYLASE AND CORTISOL, RESPECTIVELY), A SMALL TO MODERATE EFFECT SIZE WAS SEEN FAVORING A REDUCTION OF ALPHA-AMYLASE ACTIVATION FOR THE HYP GROUP (COHEN D=0.34; PREHYPERTENSIVE D=0.20). CONCLUSIONS: A SCHOOL-BASED HATHA YOGA PROGRAM DEMONSTRATED POTENTIAL TO DECREASE RESTING BP, PARTICULARLY AMONG PREHYPERTENSIVE YOUTH. REDUCED SNS DRIVE MAY BE AN UNDERLYING NEUROHORMONAL PATHWAY BENEFICIALLY AFFECTED BY THE PROGRAM. A LARGE-SCALE EFFICACY/EFFECTIVENESS RANDOMIZED CLINICAL TRIAL IS WARRANTED. 2014 18 1928 18 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007 19 1395 30 IMPACT OF YOGA BASED MIND-BODY INTERVENTION ON SYSTEMIC INFLAMMATORY MARKERS AND CO-MORBID DEPRESSION IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: RECOVERY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DEPENDS ON SEVERAL PHYSICAL AND PSYCHOLOGICAL FACTORS, BESIDES PHARMACOLOGICAL TREATMENT. CO-MORBID DEPRESSION ADVERSELY AFFECTS THE OUTCOME IN RA. USUAL MEDICAL THERAPIES HAVE A LIMITED SCOPE AND FAIL TO CURE THE PSYCHOLOGICAL COMPONENT OF THE DISEASE. WITH ADVANCED THERAPEUTIC OPTIONS, ACHIEVING A STATE OF REMISSION HAS BECOME THE TREATMENT GOAL, YOGA BASED MIND BODY INTERVENTION (MBI) MAY PROVIDE A HOLISTIC APPROACH IN ITS TREATMENT DIMENSION. HENCE, MBIS ARE THE NEED OF HOUR AS MAJORITY OF DISEASES HAVE A PSYCHOSOMATIC COMPONENT. OBJECTIVE: TO EXPLORE THE EFFECT OF YOGA BASED MBI ON DISEASE SPECIFIC INFLAMMATORY MARKERS AND DEPRESSION SEVERITY IN ACTIVE RA PATIENTS ON ROUTINE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) THERAPY. METHODS: A TOTAL OF 72 RA PATIENTS WERE RANDOMIZED INTO 2 GROUPS: YOGA GROUP (YOGA WITH DMARDS) AND CONTROL GROUP (DMARDS ONLY). BLOOD SAMPLES WERE COLLECTED PRE AND POST INTERVENTION FOR PRIMARY OUTCOME MEASUREMENTS OF SYSTEMIC BIOMARKERS. DISEASE ACTIVITY SCORE 28, ERYTHROCYTE SEDIMENTATION RATE (DAS28ESR) AND HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX (HAQ-DI) WERE USED TO ASSESS DISEASE ACTIVITY AND FUNCTIONAL STATUS RESPECTIVELY AT PRE AND POST INTERVENTION TIME-POINTS. SECONDARY OUTCOME, DEPRESSION SEVERITY, WAS ASSESSED BY BECK DEPRESSION INVENTORY II SCALE (BDI-II) AT 2 WEEKLY INTERVALS DURING 8 WEEKS OF THE STUDY INTERVENTIONAL PLAN. RESULTS: AFTER 8 WEEKS OF YOGA BASED MBI, THERE WAS SIGNIFICANT DECREASE IN THE SEVERITY OF RA AS SEEN BY REDUCTION IN LEVELS OF VARIOUS SYSTEMIC INFLAMMATORY MARKERS AS WELL AS IN DAS28ESR (P-VALUE <0.0001; EFFECT SIZE = 0.210) AND HAQ-DI (P-VALUE 0.001; EFFECT SIZE = 0.159). ALSO, YOGA GROUP EXPERIENCED A STATISTICALLY SIGNIFICANT TIME DEPENDENT STEP-WISE DECLINE IN DEPRESSION SYMPTOMS OVER THE PERIOD OF 8 WEEKS AS COMPARED TO CONTROL GROUP (P-VALUE <0.0001; EFFECT SIZE = 0.5). REGRESSION ANALYSIS SHOWED GREATER REDUCTION IN THE SCORES OF BDI-II WITH DAS28ESR (R2 = 0.426; P < 0.0001) AND HAQ-DI (R2 = 0.236; P = 0.003) IN YOGA GROUP. CONCLUSIONS: YOGA, A MIND BODY INTERVENTION RE-ESTABLISHED IMMUNOLOGICAL TOLERANCE BY AIDING REMISSION AT MOLECULAR AND CELLULAR LEVEL ALONG WITH SIGNIFICANT REDUCTION IN DEPRESSION. THUS IN THIS SEVERE AUTOIMMUNE INFLAMMATORY ARTHRITIS WITH A MAJOR PSYCHOSOMATIC COMPONENT, YOGA CAN BE USED AS A COMPLEMENTARY/ADJUNCT THERAPY. 2019 20 2210 28 THE HEALTH BENEFITS OF YOGA AND EXERCISE: A REVIEW OF COMPARISON STUDIES. OBJECTIVES: EXERCISE IS CONSIDERED AN ACCEPTABLE METHOD FOR IMPROVING AND MAINTAINING PHYSICAL AND EMOTIONAL HEALTH. A GROWING BODY OF EVIDENCE SUPPORTS THE BELIEF THAT YOGA BENEFITS PHYSICAL AND MENTAL HEALTH VIA DOWN-REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS AND THE SYMPATHETIC NERVOUS SYSTEM (SNS). THE PURPOSE OF THIS ARTICLE IS TO PROVIDE A SCHOLARLY REVIEW OF THE LITERATURE REGARDING RESEARCH STUDIES COMPARING THE EFFECTS OF YOGA AND EXERCISE ON A VARIETY OF HEALTH OUTCOMES AND HEALTH CONDITIONS. METHODS: USING PUBMED((R)) AND THE KEY WORD "YOGA," A COMPREHENSIVE SEARCH OF THE RESEARCH LITERATURE FROM CORE SCIENTIFIC AND NURSING JOURNALS YIELDED 81 STUDIES THAT MET INCLUSION CRITERIA. THESE STUDIES SUBSEQUENTLY WERE CLASSIFIED AS UNCONTROLLED (N = 30), WAIT LIST CONTROLLED (N = 16), OR COMPARISON (N = 35). THE MOST COMMON COMPARISON INTERVENTION (N = 10) INVOLVED EXERCISE. THESE STUDIES WERE INCLUDED IN THIS REVIEW. RESULTS: IN THE STUDIES REVIEWED, YOGA INTERVENTIONS APPEARED TO BE EQUAL OR SUPERIOR TO EXERCISE IN NEARLY EVERY OUTCOME MEASURED EXCEPT THOSE INVOLVING PHYSICAL FITNESS. CONCLUSIONS: THE STUDIES COMPARING THE EFFECTS OF YOGA AND EXERCISE SEEM TO INDICATE THAT, IN BOTH HEALTHY AND DISEASED POPULATIONS, YOGA MAY BE AS EFFECTIVE AS OR BETTER THAN EXERCISE AT IMPROVING A VARIETY OF HEALTH-RELATED OUTCOME MEASURES. FUTURE CLINICAL TRIALS ARE NEEDED TO EXAMINE THE DISTINCTIONS BETWEEN EXERCISE AND YOGA, PARTICULARLY HOW THE TWO MODALITIES MAY DIFFER IN THEIR EFFECTS ON THE SNS/HPA AXIS. ADDITIONAL STUDIES USING RIGOROUS METHODOLOGIES ARE NEEDED TO EXAMINE THE HEALTH BENEFITS OF THE VARIOUS TYPES OF YOGA. 2010